Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 31 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE DE LA GRAND'PLACE from Hannut, company number BE0428530063, closed financial year 2025 with a result of € 96,111 after tax. For that financial year PHARMACIE DE LA GRAND'PLACE recorded a gross margin of € 338,502 and equity of € -215,160. Compared with financial year 2024, the result moved from € -144,664 to € 96,111. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ -215,160
▲ € 96,111 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 96,111
▲ still € 144,664 loss in 2024
Profit after tax over the fiscal year.
€ 44,165
▲ 138% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -394,960.
People and assets in 2025
3
▼ 1.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 221,669
▼ 17% vs 2024
€ 73,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,943
▼ 98% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 26,710
▼ 6% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 164,319 | € 184,365 | € 138,581 | € 338,502 | ▲ 144% |
| Profit after taxes | € -88,446 | € -99,401 | € -144,664 | € 96,111 | ▲ € 240,775 |
| Equity | € -67,207 | € -166,608 | € -311,271 | € -215,160 | ▲ € 96,111 |
| Total debts | € 445,485 | € 640,097 | € 710,443 | € 638,419 | ▼ 10% |
| Cash | € 31,563 | € 78,646 | € 18,532 | € 44,165 | ▲ 138% |
| Land & buildings | € 141,963 | € 142,196 | € 132,678 | € 112,343 | ▼ 15% |
| Retained profit | € -247,007 | € -346,408 | € -491,071 | € -394,960 | ▲ € 96,111 |
| Balance sheet total | € 378,278 | € 473,490 | € 399,171 | € 423,259 | ▲ 6% |
| Employees (FTE) | 3.2 | 4 | 4.1 | 3 | ▼ 1.1 |
Key figures of PHARMACIE DE LA GRAND'PLACE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE LA GRAND'PLACE?
What happened at PHARMACIE DE LA GRAND'PLACE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 96,111. filed late Source: NBB ↗
- New establishment in Hannut. KBO
- Start of the company according to the CBE. KBO
In short
From € 88,446 loss in 2022 to € 96,111 profit in 2025.
Best year ever: 2025, with € 96,111 profit.
On average € 112,800 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE LA GRAND'PLACE? We notify you, reason included.
Follow PHARMACIE DE LA GRAND'PLACEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MANAGEMENT R.O.S.A. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DE LA GRAND'PLACEBehind PHARMACIE DE LA GRAND'PLACE is R.O.S.A Management SA. The shares are held by MANAGEMENT R.O.S.A. (99.7%).
Directors
According to the 2025 annual accounts
Managing director · represented by Alexandra Walecki
Also active at: PHARMACIE SCHUBERT
Shareholders
99.7%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Grand'Place 14
4280 Hannut
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0428.530.063
- VAT number
- BE 0428.530.063
- Registered office
- Grand'Place 14, 4280 Hannut
- Names & denominations
- PHARMACIE DE LA GRAND'PLACE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 13 February 1986
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Ontwikkeling van residentiële bouwprojecten
Projectontwikkeling voor woningbouw